Home › Funds › Pavaki Capital Management LLC › MIST
Pavaki Capital Management LLC position in MIST
MILESTONE PHARMACEUTICALS IN · Health Care
Pavaki Capital Management LLC reported holding 9,337,848 shares of MIST (MILESTONE PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$8.1M, representing 3.38% of its reported portfolio and ranking #8 among its reported holdings. Pavaki Capital Management LLC has disclosed MIST holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-26 · Source: SEC EDGAR Form 13F-HR
How Pavaki Capital Management LLC's MIST position evolved
Pavaki Capital Management LLC first disclosed a stake in MIST in Q4 2025 at 8,498,915 shares (US$17.2M). Across 4 filings, Pavaki Capital Management LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 9,337,848 shares valued at US$8.1M — an increase of 270,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 8.50M | $17.17M | New |
| Q1 2026 | 9.06M | $10.78M | Add |
| Q2 2026 | 9.07M | $12.15M | Hold |
| Q3 2026 | 9.34M | $8.08M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MIST and 13F data
MIST (MILESTONE PHARMACEUTICALS IN) is a Health Care company. 30 other funds we track also report a position in MIST — the largest reported positions include Propel Bio Management, LLC (US$10.0M), Simplify Asset Management Inc. (US$4.5M), Kalehua Capital Management LLC (US$1.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MIST
- Propel Bio Management, LLC 7.43M sh · $9.96M · Q2 2026
- Simplify Asset Management Inc. 3.35M sh · $4.49M · Q2 2026
- Kalehua Capital Management LLC 1.27M sh · $1.70M · Q2 2026
- Lion Point Capital, LP 820.00K sh · $1.10M · Q2 2026
More on Pavaki Capital Management LLC
FAQ
How long has Pavaki Capital Management LLC held MIST?
Pavaki Capital Management LLC has disclosed MIST holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Pavaki Capital Management LLC's current position in MIST?
As of Q3 2026, Pavaki Capital Management LLC holds 9.34M shares of MIST (MILESTONE PHARMACEUTICALS IN), valued at $8.08M, representing 3.38% of its reported portfolio and ranking #8.
Has Pavaki Capital Management LLC been buying or selling MIST?
In the latest 13F filing (Q3 2026), Pavaki Capital Management LLC increased its position in MIST.
Which other funds hold MIST?
Other major institutional holders of MIST include Propel Bio Management, LLC, Simplify Asset Management Inc., Kalehua Capital Management LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.